Trials / Conditions / MAP Kinase Family Gene Mutation
MAP Kinase Family Gene Mutation
3 registered clinical trials studyying MAP Kinase Family Gene Mutation — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study of Avutometinib for People With Solid Tumor Cancers NCT06104488 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Terminated | Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors NCT07121829 | Day One Biopharmaceuticals, Inc. | Phase 1 |
| Terminated | Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors NCT04985604 | Day One Biopharmaceuticals, Inc. | Phase 2 |